Neogen® To Participate in 2023 Wells Fargo Healthcare Conference


Werte in diesem Artikel
Aktien

8.18 EUR 0.10 EUR 1.19 %

LANSING, Mich., Aug. 31, 2023 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2023 Wells Fargo Healthcare Conference in Boston, Massachusetts, on Thursday, September 7.

Neogen Corporation (PRNewsfoto/Neogen Corporation)

David Naemura, Neogen's Chief Financial Officer, will present at 10:15 AM Eastern Time.

To access the webcast and presentation materials, please visit the Events & Presentations section of the Neogen Investor Relations website at neogen.com/investor-relations/events-presentations and click on the event webcast link.

About Neogen

Neogen Corporation develops and markets comprehensive solutions dedicated to food and animal safety, operating with the intention to "Every day, protect the people and animals we care about." The Company's Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. Neogen's Animal Safety segment is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, as well as rodent and insect control solutions.

Media Contact

Bill Waelke, Vice President, IR & Treasury
IR@Neogen.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-to-participate-in-2023-wells-fargo-healthcare-conference-301914468.html

SOURCE Neogen Corporation

Aktuelle Neogen Aktie News

Werbung

Neogen Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Neogen nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
31.03.11 Neogen neutral J.J.B. Hilliard, W.L. Lyons, Inc.
22.07.09 Neogen buy ROTH Capital Partners, LLC
20.03.09 Neogen buy ROTH Capital Partners, LLC
07.01.09 Neogen Kursziel gesenkt ROTH Capital Partners, LLC
26.09.08 Neogen neues Kursziel ROTH Capital Partners, LLC